Intravenous nicorandil in conjunction with coronary reperfusion therapy is associated with better clinical and functional outcomes in patients with acute myocardial infarction

Circulation Journal

Volumn 67, Issue 4, 2003, Pages 295-300

  Sugimoto, Ken ^a   Ito, Hiroshi ^a   Iwakura, Katsuomi ^a   Ikushima, Masashi ^a   Kato, Akinobu ^a   Kimura, Ryusuke ^a   Tanaka, Koji ^a   Masuyama, Tohru ^b   Ogihara, Toshio ^b   Kawano, Shigeo ^a   Fujii, Kenshi ^a  

^a Sakurabashi Watanabe Hospital   (Japan)

^b OSAKA UNIVERSITY   (Japan)

Author keywords

Contrast agent; Echocardiography; Microcirculation; Myocardial infarction; Reperfusion; Ventricular function

Indexed keywords

ACETYLSALICYLIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HEPARIN; NICORANDIL; NITRIC OXIDE; POTASSIUM CHANNEL;

ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; FEMALE; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE REPERFUSION; HEART VENTRICLE REMODELING; HUMAN; MAJOR CLINICAL STUDY; MALE; MICROCIRCULATION; PROGNOSIS; RETROSPECTIVE STUDY; RISK; TREATMENT OUTCOME;

EID: 0037390281     PISSN: 13469843     EISSN: None     Source Type: Journal    
DOI: 10.1253/circj.67.295     Document Type: Article

References (22)

1. Hillis LD, Former S, Braunwald E. Risk stratification before thrombolytic therapy in patients with acute myocardial infarction. J Am Coll Cardiol 1990; 16: 313-315.
2. Gruppo Italiano per lo Studio Della Streptokinesi Nell' Infarcto Micardico (GISSI). Effectiveness of intravenous thrombolytic treatment in acute myocardial infarction. Lancet 1986; 1: 397-401.
3. Kennedy JW, Ritchie JL, Davis KB, Fritz JK. Western Washington randomized trial of intracoronary streptokinase in acute myocardial infarction. N Engl J Med 1983; 309: 1477-1482.
4. Sakata Y, Kodama K, Momamura K, Lim YJ, Ishikura F, Hirayama A, et al. Salutary effect of adjunctive intracoronary nicorandil administration on restoration of myocardial blood flow and functional improvement in patients with acute myocardial infarction. Am Heart J 1997; 133: 616-621.
5. Taniyama Y, Ito H, Iwakura K, Masuyama T, Hori M, Takiuchi S, et al. Beneficial effect of intracoronary verapamil on microvascular and myocardial salvage in patients with acute myocardial infarction. J Am Coll Cardiol 1997; 30: 1193-1199.
6. Mahaffey KW, Puma JA, Barbagelata A, DiCarli MF, Leesar MA, Browne KF, et al. Adenosine as an adjunct to thrombolytic therapy for acute myocardial infarction. J Am Coll Cardiol 1999; 34: 1711-1720.
7. Marzilli M, Orsini E, Marraccini P, Testa R. Beneficial effects of intracoronary adenosine as an adjunct to primary angioplasty in acute myocardial infarction. Circulation 2000; 101: 2154-2159.
8. Ito H, Taniyama Y, Iwakura K, Nishikawa N, Masuyama T, Kuzuya T, et al. Intravenous nicorandil can preserve microvascular integrity and myocardial viability in patients with reperfused anterior wall myocardial infarction. J Am Coll Cardiol 1999; 33: 654-660.
9. Sato T, Sasaki N, O'Rouke B, Marban E. Nicorandil, a potent cardioprotective agent, acts by opening mitochondrial ATP-dependent potassium channels. J Am Coll Cardiol 2000; 35: 514-518.
10. Cheesebro JH, Knatterud G, Roberts R, Borer J, Cohen LS, Dalen J, et al. Thrombolysis in myocardial infarction (TIMI) trial. Phase I: A comparison between intravenous plasminogen activator and intravenous streptokinase: Clinical findings through hospital discharge. Circulation 1987; 76: 142-154.
11. Ito H, Tomooka T, Sakai N, Yu H, Higashino Y, Fujii K, et al. Lack of myocardial perfusion immediately after successful thrombolysis: A predictor of poor recovery of left ventricular function in anterior myocardial infarction. Circulation 1992; 85: 1699-1705.
12. Ito H, Tomooka T, Sakai N, Higashino Y, Fujii K, Katoh O, et al. Time course of functional improvement in stunned myocardium in risk area in patients with reperfused anterior infarction. Circulation 1993; 87: 355-362.
13. Ito H, Iwakura K, Oh H, Masuyama T, Hori M, Higashino Y, et al. Recovery of coronary microcirculation after coronary reflow in patients with anterior wall acute myocardial infarction: Its correlates to myocardial viability. Circulation 1995; 91: 656-662.
14. Cohen M, Rentrop KP. Limitation of myocardial ischemia by collateral circulation during sudden controlled coronary artery occlusion in human subjects: A prospective study. Circulation 1986; 74: 469-476.
15. Pfeffer MA, Braunwald E. Ventricular remodeling after myocardial infarction: Experimental observations and clinical implications. Circulation 1990; 81: 1161-1172.
16. Ito H, Maruyama A, Iwakura K, Takiuchi S, Masuyama T, Hori M, et al. Clinical implications of 'no reflow' phenomenon: A predictor of complications and left ventricular remodeling in reperfused anterior wall myocardial infarction. Circulation 1996; 93: 223-228.
17. Mizunuma T, Nithiapatikom K, Gross GJ. Bimakalim, an ATP-sensitive potassium channel opener, mimics the effects of ischemic preconditioning to reduce infarct size, adenosine release, and neutrophil function in dogs. Circulation 1995; 92: 1236-1245.
18. Mizunuma T, Nithipatikom K, Gross GJ. Effects of nicorandil and glyceryl trinitrate on infarct size, adenosine release, and neutrophil infiltration in the dog. Cardiovasc Res 1995; 29: 482-489.
19. Galie N, Guarnieri C, Ussia GP, Zimarino M, Traini AM, Parlangeli R, et al. Limitation of myocardial infarct size by nicorandil after sustained ischemia in pigs. J Cardiovasc Pharmacol 1995; 26: 477-484.
20. Akai K, Wang Y, Sato K, Sekiguchi N, Sugimura A, Kumagai T, et al. Vasodilatory effect of nicorandil on coronary arterial microvessels: Its dependency on vessel size and the involvement of the ATP-sensitive potassium channel. J Cardiovasc Pharmacol 1995; 26: 541-547.
21. Stahl LD, Aversano TR, Becker LC. Selective enhancement of function of stunned myocardium by increased flow. Circulation 1986; 74: 843-851.
22. Gibbons RJ, Christian TF, Hopfenspirger M, Hodge DO, Bailey KR. Myocardium at risk and infarct size after thrombolytic therapy for acute myocardial infarction: Implications for the design of randomized trials of acute intervention. J Am Coll Cardiol 1994; 24: 616-623.